Kristian Reich

Company: MoonLake

Job title: Co-Founder & Chief Scientific Officer

Seminars:

Rethinking HS Disease Assessment: Bridging the Gap Between Inflammatory Mechanisms and Regulatory Endpoints 9:00 am

Understanding current clinical endpoint frameworks for Hidradenitis Suppurativa and their limitations in accurately measuring disease activity  Emerging differences in regulatory view? A hot debate: HiSCR vs. IHS4  Future direction: Aligning trial design with treatment goals putting inflammatory burden and PROs in the centerRead more

day: Day Two

Panel Discussion: Strategic Considerations for Clinical Success in Hidradenitis Suppurativa 9:30 am

Explore how leading developers are balancing the need for regulatory-aligned endpoints with endpoints that demonstrate value to payers and patients  Debate strategies for designing more efficient trials through novel endpoint combinations and timing of assessments to accelerate development timelines  Understand different approaches to generating compelling evidence packages that support both regulatory approval and market access…Read more

day: Day Two